AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.2 |
Market Cap | 7.52M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.14 |
PE Ratio (ttm) | -0.6 |
Forward PE | n/a |
Analyst | Hold |
Ask | 1.28 |
Volume | 133,404 |
Avg. Volume (20D) | 1,293,793 |
Open | 1.37 |
Previous Close | 1.50 |
Day's Range | 1.27 - 1.42 |
52-Week Range | 0.56 - 3.45 |
Beta | undefined |
About CHEK
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through ...
Analyst Forecast
According to 1 analyst ratings, the average rating for CHEK stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.